Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection
- PMID: 39101178
- PMCID: PMC11291795
- DOI: 10.1007/s13340-024-00729-2
Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection
Abstract
There is growing evidence suggesting an association between severe acute respiratory coronavirus syndrome coronavirus 2 (SARS-CoV-2) infection and various extrapulmonary diseases since the advent of coronavirus disease 2019 (COVID-19) pandemic. However, case reports of fulminant type 1 diabetes mellitus (FT1D) following SARS-CoV-2 infection are limited. We encountered a 44-year-old Japanese woman who developed FT1D accompanied by subclinical thyrotoxicosis caused by autoimmune thyroid disease (AITD) approximately one week after SARS-CoV-2 infection. The patient developed fever and flu-like symptom 4 days before transportation and tested positive then for the SARS-CoV-2 antigen self-test. She subsequently developed sudden thirst, polyuria, and fatigue of 1 day duration and was urgently brought to our emergency room. Laboratory findings indicated diabetic ketoacidosis (DKA) without marked elevation of serum glycated hemoglobin (HbA1c) levels (glucose, 930 mg/dL; HbA1c, 7.4%). Her insulin secretory capacity was almost completely depleted, and islet-specific autoantibodies were negative. Endocrine examinations revealed subclinical thyrotoxicosis, which was positive for thyroid stimulation hormone receptor antibodies. Based on these results, the patient was diagnosed with FT1D accompanied by AITD and immediately started on intensive insulin therapy with a basal-bolus subcutaneous insulin regimen. Human leukocyte antigen analysis revealed haplotypes, indicating susceptibility to both FT1D and AITD. Further studies are required to elucidate the causal relationship between SARS-CoV-2 infection, FT1D, and AITD. However, clinicians must be vigilant about possible development of FT1D and AITD to enable accurate diagnosis and treatment of patients with DKA during the COVID-19 pandemic.
Keywords: Autoimmune thyroid disease; Diabetic ketoacidosis; Fulminant type 1 diabetes mellitus; Severe respiratory coronavirus syndrome coronavirus 2.
© The Japan Diabetes Society 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestTetsuyuki Yasuda has received lecture fees from Eli Lilly Japan K.K., Sumitomo Pharma Co. Ltd., Novo Nordisk Pharma Ltd., and Mitsubishi Tanabe Pharma Co., Ltd. The other authors declare that they have no conflict of interest.
Similar articles
-
Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic.Biology (Basel). 2022 Nov 15;11(11):1662. doi: 10.3390/biology11111662. Biology (Basel). 2022. PMID: 36421377 Free PMC article. Review.
-
Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies.Front Endocrinol (Lausanne). 2022 Aug 10;13:983206. doi: 10.3389/fendo.2022.983206. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36034456 Free PMC article.
-
Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy.Front Endocrinol (Lausanne). 2023 Apr 4;14:1168927. doi: 10.3389/fendo.2023.1168927. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37082120 Free PMC article.
-
The fulminant index: A method of rapidly differentiating fulminant type 1 diabetes from diabetic ketoacidosis.Diabetes Metab Res Rev. 2022 Mar;38(3):e3501. doi: 10.1002/dmrr.3501. Epub 2021 Oct 13. Diabetes Metab Res Rev. 2022. PMID: 34614535
-
New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review.J Korean Med Sci. 2023 Jun 19;38(24):e209. doi: 10.3346/jkms.2023.38.e209. J Korean Med Sci. 2023. PMID: 37337812 Free PMC article. Review.
References
-
- Imagawa A, Hanafusa T, Awata T, Ikegami H, Uchigata Y, Osawa H, et al. Report of the committee of the Japan diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012). J Diabetes Investig. 2012;3:536–9. 10.1111/jdi.12024 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous